Loading…
Pharmaceuticals and Healthcare · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 0% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Debt / 36-month avg market cap | 0% | < 33% | Pass |
| Cash + interest-bearing securities / 36-month avg market cap | 0.66% | < 33% | Pass |
| Accounts receivable / 36-month avg market cap | 0% | < 33% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free0% of any dividend from GLAND should be given to charity. Calculate your amount →
Very strong positive returns across all horizons, a bullish moving-average setup, and trading close to its 52-week high indicate a powerful uptrend. High volatility reflects the intensity of the recent move.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.